Drug Information Association's New Leadership Outlines Vision Of Group's Future In Asia: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Drug Information Association President Richard Day, the association's new leader, along with DIA Worldwide Executive Director Paul Pomerantz and China Director Steven Basart sat down with PharmAsia News during the Second Annual DIA China meeting in Beijing in May to discuss DIA's strategy and global mission. Day, Executive Director of the Clinical Trials Center in New South Wales, Australia, is the first non-American to run the association, which has offices in the U.S., Switzerland, Japan, India and China.
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)